Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG

S Morioka, GS Lazarus, PJ Jensen - Journal of investigative dermatology, 1987 - Elsevier
S Morioka, GS Lazarus, PJ Jensen
Journal of investigative dermatology, 1987Elsevier
Pemphigus IgG induces acantholysis in skin organ culture without the involvement of
complement. Urokinase-type plasminogen activator, a proteolytic enzyme, has been
implicated in the development of acantholysis. To test this hypothesis, we prepared a rabbit
anti-urokinase antibody, which inhibited the plasminogen activator activity in normal human
epidermis and in cultured keratinocytes. When added to skin organ cultures along with
pemphigus IgG, anti-urokinase IgG completely prevented the development of acantholysis …
Pemphigus IgG induces acantholysis in skin organ culture without the involvement of complement. Urokinase-type plasminogen activator, a proteolytic enzyme, has been implicated in the development of acantholysis. To test this hypothesis, we prepared a rabbit anti-urokinase antibody, which inhibited the plasminogen activator activity in normal human epidermis and in cultured keratinocytes. When added to skin organ cultures along with pemphigus IgG, anti-urokinase IgG completely prevented the development of acantholysis. Normal or preimmune rabbit IgG had no effect on pemphigus IgG-induced acantholysis. Plasminogen activator converts the zymogen plasminogen to its active form plasmin, a broad specificity serine proteinase. When high concentrations of plasminogen alone were added to skin organ culture, acantholysis of the pemphigus foliaceous type was induced. Anti-urokinase antibody also inhibited plasminogen-induced acantholysis. These results strongly support a pivotal role for plasminogen activator in the development of acantholysis.
Elsevier